Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clones.

Blood
Christoph SchanielA G Rolink

Abstract

Self-renewal, pluripotency, and long-term reconstitution are defining characteristics of single hematopoietic stem cells. Pax5(-/-) precursor B cells apparently possess similar characteristics. Here, using serial transplantations, with in vitro recloning and growth of the bone marrow-homed donor cells occurring after all transplantations, we analyzed the extent of self-renewal and hematopoietic multipotency of Pax5(-/-) precursor B-cell clones. Moreover, telomere length and telomerase activity in these clones was analyzed at various time points. Thus far, 5 successive transplantations have been performed. Clones transplanted for the fifth time, which have proliferated for more than 150 cell divisions in vitro, still repopulate the bone marrow with precursor B cells and reconstitute these recipients with lymphoid and myeloid cells. During this extensive proliferation, Pax5(-/-) precursor B cells shorten their telomeres at 70 to 90 base pairs per division. Their telomerase activity remains at 3% of that of HEK293 cancer cells during all serial in vivo transplantations/in vitro expansions. Together, these data show that Pax5(-/-) precursor B-cell clones possess extensive in vivo self-renewal capacity, long-term reconstitution capa...Continue Reading

References

May 1, 1978·The Journal of Experimental Medicine·D E HarrisonJ A Delaittre
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R C AllsoppC B Harley
Jul 1, 1992·Experimental Gerontology·C B HarleyR C Allsopp
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·L G SmithS Heimfeld
Feb 1, 1990·Genes & Development·C T Jordan, I R Lemischka
Sep 27, 1990·Nature·D Kipling, H J Cooke
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D E HarrisonC Lerner
Jul 1, 1988·Science·G J SpangrudeI L Weissman
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·H VaziriP M Lansdorp
May 2, 1994·Journal of Immunological Methods·A B Lyons, C R Parish
Sep 1, 1996·Nature Medicine·S J MorrisonI L Weissman
Jan 1, 1996·Annual Review of Biochemistry·C W Greider
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·S H CheshierI L Weissman
Aug 4, 1999·The Journal of Experimental Medicine·R J Hodes
Aug 1, 1964·Journal of Cellular Physiology·L SIMINOVITCHE A MCCULLOCH
Mar 1, 1965·Experimental Cell Research·L HAYFLICK

❮ Previous
Next ❯

Citations

Apr 12, 2011·Cancer Immunology, Immunotherapy : CII·Yeranddy A AlpizarN Avrion Mitchison
May 15, 2002·Immunology Letters·Antonius G RolinkFritz Melchers
Mar 1, 2002·Current Opinion in Immunology·Michael SchebestaMeinrad Busslinger
Apr 19, 2007·Nature Immunology·César CobaledaMeinrad Busslinger
Nov 14, 2007·Immunology and Cell Biology·Melissa L HolmesStephen L Nutt
Apr 12, 2003·Current Opinion in Hematology·Hongfang Wang, Gerald J Spangrude
Mar 23, 2004·Annual Review of Immunology·Meinrad Busslinger
Oct 9, 2002·Immunological Reviews·Antonius G RolinkFritz Melchers
May 30, 2013·European Journal of Immunology·Marko KnollFritz Melchers
Dec 1, 2009·Chemico-biological Interactions·Jonas RenströmRobert A J Oostendorp
Feb 20, 2007·Current Opinion in Immunology·Min Ye, Thomas Graf
Jan 27, 2005·Stem Cells·Ko-Tung ChangEmanuel Necas
Feb 19, 2005·European Journal of Immunology·Laurence ArdouinBernard Malissen
Nov 18, 2006·European Journal of Immunology·Sebastian CarottaStephen L Nutt
Aug 8, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Xiao-Dong ChenRobert L Jilka
Nov 1, 2007·European Journal of Immunology·Fritz Melchers
Feb 23, 2008·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Sebastian Carotta, Stephen L Nutt
Dec 9, 2003·The Journal of Clinical Investigation·Akihisa SawadaJunichi Hara
Mar 20, 2004·Immunity·Tomokatsu IkawaCornelis Murre
Jan 7, 2014·Cell Stem Cell·Peter van GalenJohn E Dick
Aug 8, 2012·Blood·Oliver Weigert, David M Weinstock
Feb 26, 2004·Journal of Leukocyte Biology·Emma Smith, Mikael Sigvardsson
Apr 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hiromu SatoAkira Kudo
Jan 11, 2020·Frontiers in Immunology·Cristiana F PiresCarlos-Filipe Pereira
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Martin Fuxa, Meinrad Busslinger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.